AL-S Pharma AG | Finanzwire

Basculer en Français

10817	Companies
234430	Keywords
163287	Articles
125437	Press releases

Home
Companies
AL-S Pharma AG

BRIEF

published on 06/24/2026 at 17:25, 1 month 16 days ago

AL-S Pharma Reports Positive AP-101 Phase 2 Findings for ALS Treatment

Clinical Trial ALS Treatment Phase 2 Data SOD1 Misfolding AP-101 Antibody
PRESS RELEASE

published on 06/24/2026 at 17:20, 1 month 16 days ago

AL-S Pharma Presents AP-101 Phase 2 Data Supporting Misfolded SOD1 as a Therapeutic Target in ALS at ENCALS 2026
AL-S Pharma presents Phase 2 data on AP-101 supporting misfolded SOD1 as ALS therapeutic target at ENCALS 2026. Key study results and clinical implications discussed

ALS Phase 2 Data SOD1 AL-S Pharma ENCALS 2026
BRIEF

published on 03/19/2026 at 07:35, 4 months 22 days ago

AL-S Pharma's AP-101 Shows Promise in ALS Treatment

Clinical Trial ALS Treatment Phase 2 Data AP-101 SOD1 Targeting
PRESS RELEASE

published on 03/19/2026 at 07:30, 4 months 22 days ago

Additional Phase 2 Data of AL-S Pharma’s Lead Program AP-101 Further Demonstrate Clinically Meaningful Disease Modification and Prolonged Survival in ALS
AL-S Pharma AG presents additional Phase 2 data of lead program AP-101 at AD/PD International Conference showing disease modification in ALS patients. AP-101 targets misfolded SOD1 to inhibit disease progression

ALS Phase 2 Data AP-101 AL-S Pharma AG SOD1

Accesswire

Published on 08/11/2026 at 00:40, 3 hours 20 minutes ago

CORRECTION FROM SOURCE: Fermi Announces Binding Lease Agreement with TensorWave
Published on 08/11/2026 at 00:25, 3 hours 35 minutes ago

Empress Reports 2026 Second Quarter Financial Results
Published on 08/10/2026 at 23:35, 4 hours 25 minutes ago

NioCorp Project to Expand Production to 8 Made-in-USA Critical Minerals Over a 40-Year Mine Life with an Estimated $4.1 Billion Pre-Tax NPV8%
Published on 08/10/2026 at 23:30, 4 hours 30 minutes ago

Condor and Element79 Agree on Restructured Terms for Lucero Project
Published on 08/10/2026 at 23:25, 4 hours 35 minutes ago

Ur-Energy Reports Second Quarter 2026 Results

View all ACCESSWIRE

EQS Group

Published on 08/10/2026 at 22:15, 5 hours 45 minutes ago

Amrize Files Form 10-Q for Second Quarter 2026
Published on 08/10/2026 at 22:05, 5 hours 55 minutes ago

Immunic Appoints Elena Ridloff to Board of Directors
Published on 08/10/2026 at 20:24, 7 hours 35 minutes ago

EQS-Adhoc: PNE AG updates on ongoing sales process
Published on 08/10/2026 at 19:35, 8 hours 25 minutes ago

Kontron AG: All conditions of the mandatory tender offer of Ennoconn Corporation are met – Settlement will take place shortly
Published on 08/10/2026 at 18:29, 9 hours 30 minutes ago

Fuller, Smith & Turner PLC: Director/PDMR Shareholdings

Les Echos

Published on 08/10/2026 at 18:00, 10 hours ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 17:45, 10 hours 15 minutes ago

Weekly share buyback
Published on 08/10/2026 at 11:53, 16 hours 6 minutes ago

GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
Published on 08/10/2026 at 11:36, 16 hours 23 minutes ago

GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026
Published on 08/10/2026 at 09:22, 18 hours 37 minutes ago

Number of shares and voting rights - July 2026 (In French only)

View all LES ECHOS COMFI WIRE